Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease

Alzheimer’s disease, which is characterized by gradual cognitive decline associated with deterioration of daily living activities and behavioral disturbances throughout the course of the disease, is estimated to affect 27 million people around the world. It is expected that the illness will affect a...

Descripción completa

Detalles Bibliográficos
Autores principales: Novakovic, Dijana, Feligioni, Marco, Scaccianoce, Sergio, Caruso, Alessandra, Piccinin, Sonia, Schepisi, Chiara, Errico, Francesco, Mercuri, Nicola B, Nicoletti, Ferdinando, Nisticò, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832388/
https://www.ncbi.nlm.nih.gov/pubmed/24255592
http://dx.doi.org/10.2147/DDDT.S53401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832388/
https://www.ncbi.nlm.nih.gov/pubmed/24255592
http://dx.doi.org/10.2147/DDDT.S53401

Ejemplares similares